Flotation-REST for Chronic Pain, Stress, and Sleep
Primary Purpose
Healthy, Chronic Pain, Musculoskeletal Pain
Status
Withdrawn
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Flotation-REST
Dark Room
Sponsored by
About this trial
This is an interventional treatment trial for Healthy focused on measuring Healthy, Chronic Pain, Floatation-REST, Floating
Eligibility Criteria
Inclusion Criteria:
- Chronic musculoskeletal pain (e.g., back pain or upper or lower extremity pain, arthritis, fibromyalgia) on more days than not for the past 3 months
- Psychologically healthy
- Adults between the ages of 18-75 years.
Exclusion Criteria:
- Previous experience in a flotation-REST device.
- Diagnosed with neuropathic pain condition or endorsing more than 4 peripheral neuropathy symptoms.
- Diagnosed with any psychiatric condition (e.g., schizophrenia or bipolar disorder).
- Active suicidality with intent or plan.
- Currently taking SSRI medication.
- History of neurological conditions (e.g., epilepsy, stroke, severe traumatic brain injury, Parkinson's disease, Alzheimer's disease or other forms of dementia)
- Any skin conditions or open wounds that could cause pain when exposed to saltwater
- Inability to lay comfortably for 60 minutes
- Pregnant
- Started a new sleep or pain medication within the last 6 weeks
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Floatation-REST
Dark Room
Arm Description
Participants will float in a shallow pool of water with about 1000 pounds of epsom salt, in a light and sound attenuated device, for up to 60 minutes. Following the session, participants' ratings of the experience will be measured.
Participants will lay on an air mattress in a dark and quiet room, with reduced environmental stimulation, for up to 60 minutes. Following the session, participants' ratings of the experience will be measured.
Outcomes
Primary Outcome Measures
Pain intensity
Change in daily pain intensity where higher scores represent greater pain reduction using the Brief Pain Inventory
Pain Unpleasantness
Change in daily pain unpleasantness where higher scores represent greater pain unpleasantness using the Brief Pain Inventory.
Stress
Changes in perceived stress scale and daily diary assessments of stress where higher scores represent higher levels of stress.
Sleep
Sleep Health Index and daily electronic dairies will be used to record sleep parameters. Higher sleep quality represents better sleep.
Secondary Outcome Measures
Change in pain interference
Change in daily pain interference where higher scores represent interference in daily activities from pain using the Brief Pain Inventory.
Change in muscle tension or tightness
Average change in muscle tension from pre- to post-intervention where higher scores indicate greater muscle tension.
Change in self-actualization from baseline
Self-actualization Scale; 5-point Likert-type scale where the highest score indicates strongest self-actualization
Interoception
Self-reported interoception assessed with the Multidimensional Interoceptive Awareness Scale after each intervention where higher scores indicate greater interoception during the session.
Insight
Self-reported insights assessed with the Psychological Insight Questionnaire after each intervention where higher scores indicate more insight occurred during the session.
Emotional Breakthrough
Self-reported emotional breakthrough assessed with the Emotional Breakthrough Inventory after each intervention where higher scores indicate more emotional breakthrough occurred during the session.
Mystical Experiences
Self-reported mystical experiencesassessed with the Mystical Experiences Questionnaire after each intervention where higher scores indicate more mystical-type experiences occurred during the session.
Change in perceived stress
Perceived Stress Scale; assesses changes in perceived stress where higher scores indicate greater levels of stress
Change in Pain Catastrophizing
Pain Catastrophizing Scale; assesses changes in pain catastrophizing where higher scores indicate greater levels of pain catastrophizing
Change in Depression
Becks Depressive Inventory II; assesses changes in depression where higher scores indicate greater levels of depression
Persisting Effects
Persisting Effects Questionnaire: scale of 0 - 5 where 5 is the strongest persisting effect
Full Information
NCT ID
NCT04155268
First Posted
October 18, 2019
Last Updated
September 8, 2020
Sponsor
University of Missouri-Columbia
1. Study Identification
Unique Protocol Identification Number
NCT04155268
Brief Title
Flotation-REST for Chronic Pain, Stress, and Sleep
Official Title
Daily Assessments of Pain, Stress, and Sleep Following Flotation-REST: A Randomized Crossover Trial for Those With Chronic Pain
Study Type
Interventional
2. Study Status
Record Verification Date
September 2020
Overall Recruitment Status
Withdrawn
Why Stopped
Unable to conduct the study due to Covid-19.
Study Start Date
March 9, 2020 (Anticipated)
Primary Completion Date
September 8, 2020 (Actual)
Study Completion Date
September 8, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Missouri-Columbia
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This randomized crossover trial aims to examine the effects of Flotation-REST (Reduced, Environmental, Stimulation, Technique/Therapy) compared to laying in a dark room (with reduced environmental stimulation) for those with chronic musculoskeletal pain. This design will allow for comparisons between the two interventions on daily diary assessments of pain, stress, and sleep, both between groups and within individuals.
Detailed Description
Chronic pain is a prevalent and significant health problem. Previous research shows that Flotation-REST may be an effective treatment for reducing pain but little is known about the short-term effects of a single session of Flotation-REST on the day-to-day variability of pain, stress, and sleep. Sleep, stress, and pain are all bidirectionally related to each other, and previous research shows that Flotation-REST may positively influence all three of these outcomes. Therefore, the primary aim of this study is to examine changes in pain, stress, and sleep following Flotation-REST. The secondary aim is to investigate whether various subjective experiences during the intervention are associated with changes in pain, stress, and sleep following the interventions.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Healthy, Chronic Pain, Musculoskeletal Pain
Keywords
Healthy, Chronic Pain, Floatation-REST, Floating
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Floatation-REST
Arm Type
Experimental
Arm Description
Participants will float in a shallow pool of water with about 1000 pounds of epsom salt, in a light and sound attenuated device, for up to 60 minutes. Following the session, participants' ratings of the experience will be measured.
Arm Title
Dark Room
Arm Type
Active Comparator
Arm Description
Participants will lay on an air mattress in a dark and quiet room, with reduced environmental stimulation, for up to 60 minutes. Following the session, participants' ratings of the experience will be measured.
Intervention Type
Behavioral
Intervention Name(s)
Flotation-REST
Intervention Description
Floating in a specialized device (float pod or float cabin) used to attenuate sensory input.
Intervention Type
Behavioral
Intervention Name(s)
Dark Room
Intervention Description
Participants will lay on an air mattress in a dark room with no cell phone and reduced sensory input.
Primary Outcome Measure Information:
Title
Pain intensity
Description
Change in daily pain intensity where higher scores represent greater pain reduction using the Brief Pain Inventory
Time Frame
From baseline to follow-up, approximately 2 weeks
Title
Pain Unpleasantness
Description
Change in daily pain unpleasantness where higher scores represent greater pain unpleasantness using the Brief Pain Inventory.
Time Frame
From baseline to follow-up, approximately 2 weeks
Title
Stress
Description
Changes in perceived stress scale and daily diary assessments of stress where higher scores represent higher levels of stress.
Time Frame
From baseline to follow-up, approximately 2 weeks
Title
Sleep
Description
Sleep Health Index and daily electronic dairies will be used to record sleep parameters. Higher sleep quality represents better sleep.
Time Frame
From baseline to follow-up, approximately 2 weeks
Secondary Outcome Measure Information:
Title
Change in pain interference
Description
Change in daily pain interference where higher scores represent interference in daily activities from pain using the Brief Pain Inventory.
Time Frame
From baseline to follow-up, approximately 2 weeks
Title
Change in muscle tension or tightness
Description
Average change in muscle tension from pre- to post-intervention where higher scores indicate greater muscle tension.
Time Frame
Immediately before and after each intervention
Title
Change in self-actualization from baseline
Description
Self-actualization Scale; 5-point Likert-type scale where the highest score indicates strongest self-actualization
Time Frame
Baseline, 1- week and 1-month after intervention
Title
Interoception
Description
Self-reported interoception assessed with the Multidimensional Interoceptive Awareness Scale after each intervention where higher scores indicate greater interoception during the session.
Time Frame
Immediately after each intervention
Title
Insight
Description
Self-reported insights assessed with the Psychological Insight Questionnaire after each intervention where higher scores indicate more insight occurred during the session.
Time Frame
Immediately after each intervention
Title
Emotional Breakthrough
Description
Self-reported emotional breakthrough assessed with the Emotional Breakthrough Inventory after each intervention where higher scores indicate more emotional breakthrough occurred during the session.
Time Frame
Immediately after each intervention
Title
Mystical Experiences
Description
Self-reported mystical experiencesassessed with the Mystical Experiences Questionnaire after each intervention where higher scores indicate more mystical-type experiences occurred during the session.
Time Frame
Immediately after each intervention
Title
Change in perceived stress
Description
Perceived Stress Scale; assesses changes in perceived stress where higher scores indicate greater levels of stress
Time Frame
Baseline and 1-week after each intervention
Title
Change in Pain Catastrophizing
Description
Pain Catastrophizing Scale; assesses changes in pain catastrophizing where higher scores indicate greater levels of pain catastrophizing
Time Frame
Baseline and 1-week after each intervention
Title
Change in Depression
Description
Becks Depressive Inventory II; assesses changes in depression where higher scores indicate greater levels of depression
Time Frame
Baseline and 1-week after each intervention
Title
Persisting Effects
Description
Persisting Effects Questionnaire: scale of 0 - 5 where 5 is the strongest persisting effect
Time Frame
1-week after each intervention
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Chronic musculoskeletal pain (e.g., back pain or upper or lower extremity pain, arthritis, fibromyalgia) on more days than not for the past 3 months
Psychologically healthy
Adults between the ages of 18-75 years.
Exclusion Criteria:
Previous experience in a flotation-REST device.
Diagnosed with neuropathic pain condition or endorsing more than 4 peripheral neuropathy symptoms.
Diagnosed with any psychiatric condition (e.g., schizophrenia or bipolar disorder).
Active suicidality with intent or plan.
Currently taking SSRI medication.
History of neurological conditions (e.g., epilepsy, stroke, severe traumatic brain injury, Parkinson's disease, Alzheimer's disease or other forms of dementia)
Any skin conditions or open wounds that could cause pain when exposed to saltwater
Inability to lay comfortably for 60 minutes
Pregnant
Started a new sleep or pain medication within the last 6 weeks
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Steven Pratscher
Organizational Affiliation
University of Missouri-Columbia
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Flotation-REST for Chronic Pain, Stress, and Sleep
We'll reach out to this number within 24 hrs